Navigation Links
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

NEW YORK, March 20 /PRNewswire/ -- QED International Associates Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange-Traded Funds, today announced the quarterly rebalancing of the Indexes. The following securities will be added and deleted in the Indexes effective before the opening of trading on NYSE Arca March 24, 2008.

Autoimmune-Inflammation Index (HHA)


GW Pharmaceuticals, Inc (LSE: GWP.L)

Human Genome Sciences (Nasdaq: HGSI)

Ligand Pharmaceuticals, Inc. (Nasdaq: LGND)


Fornix Biosciences N.V. (Amsterdam: FORBI.AS)


Mitsubishi Tanabe Pharma Corporation (TSE: 4508)

Cancer Index (HHK)


Shire PLC (Nasdaq: SHPGY)


Ark Therapeutics Group Plc (LSE: AKT.L)

Cardio Devices Index (HHE)


Biosphere Medical, Inc. (Nasdaq: BSMD)


Zoll Medical Corp. (Nasdaq: Add

Dyanvax Technologies (Nasdaq: DVAX)

Synta Pharmaceuticals Corp. (Nasdaq: SNTA)

Enabling Technologies Index (HHV)


Hillenbrand Industries (NYSE: HB)


Eurand N.V. (Nasdaq: EURX)

GI/Gender Index (HHU)


AEterna Zentaris (Nasdaq: AEZS)

King Pharmaceuticals (NYSE: KG)

Nastech Pharmaceutical (Nasdaq: NSTK)


Columbia Laboratories Inc. (Nasdaq: CBRX)

Eisai Co. Ltd. (Tokyo Stock Exchange: 4523)

Mylan, Inc. (NYSE: MYL)

Metabolic-Endocrine Disorders Index (HHM)


Depomed Inc. (Nasdaq: DEPO)

Emisphere Technologies Inc. (Nasdaq: EMIS)

Flamel Technologies SA ADS (Nasdaq: FLML)

Hospira Inc. (NYSE: HSP)

Human Genome Sciences, Inc. (Nasdaq: HGSI)

Indevus Pharmaceuticals Inc. (Nasdaq: IDEV)

Ipsen Ltd. (Paris: IPN.PR)

Nektar Therapeutics (Nasdaq: NKTR)

NicOx S.A. (Paris: NCOX)

OSI Pharmaceuticals Inc. (Nasdaq: OSIP)

ProStrakan Group Plc (LSE: PSK.L)

Solvay S.A. (Brussels: SVYSY)


Altus Pharmaceuticals Inc. (Nasdaq: ALTU)

Amicus Therapeutics, Inc. (Nasdaq: FOLD)

Biodell Inc. (Nasdaq: BIOD)

CombinatoRx Inc. (Nasdaq: CRXX)

GW Pharmaceuticals Plc (LSE: GWP.L)

Incyte Corp. (Nasdaq: INCY)

Orexigen Therapeutics, Inc. (Nasdaq: OREX)

Repros Therapeutics Inc. (Nasdaq: RPRX)

Sirtris Pharmaceuticals, Inc. (Nasdaq: SIRT)

SuperGen Inc. (Nasdaq: SUPG)

Transition Therapeutics Inc. (Nasdaq: TTHI)

XOMA Ltd. (Nasdaq: XOMA)

Neuroscience Index (HHN)


Neurochem Inc. (Nasdaq: NRMX)


Caraco Pharmaceutical Laboratories Ltd. (Amex: CPD)

Ophthalmology Index (HHZ)


Insite Vision Inc. (Amex: ISV)


King Pharmaceuticals (NYSE: KG)

Patient Care Services Index (HHB)


Fresenius Medical Care (XETRA: FME.DE)


Coventry Health Care Inc. (NYSE: CVH)

The rebalanced Indexes, including the rebalanced Index Shares, are based on the closing prices as of March 14, 2008.

In accordance with the Exemptive Order, a complete list of the constituents reflecting the rebalancing will be posted at

About QED International Associates

QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at

ick="var s=s_gi(s_account); var hd1 = document.getElementById('headline');,'o',getLinkName('Company Sanpshot'));" >ZOLL)

Cardiology Index (HRD)


Encysive Pharmaceuticals, Inc. (Nasdaq: ENCY)

Human Genome Sciences, Inc (Nasdaq: HGSI)

Vical, Inc. (Nasdaq: VICL)


Mitsubishi Tanabe Pharma Corporation (TSE: 4508)

Sangamo BioSciences Inc. (Nasdaq: SGMO)

Sciele Pharma, Inc. (Nasdaq: SCRX)

Composite Index (HHQ)


Advanced Medical Optics, Inc. (NYSE: EYE)

Align Technology Inc. (Nasdaq: ALGN)

Array Biopharma Inc. (Nasdaq: ARRY)

ArthroCare Corp. (Nasdaq: ARTC)

Endo Pharmaceuticals Hldgs. (Nasdaq: ENDP)

Fresenius Medical Care AG (XETRA: FME.DE)


GENMAB A/S (Copenhagen: GEN.CO)

H LUNDBECK A/S (Copenhagen: LUN.CO)

Human Genome Sciences (Nasdaq: HGSI)

Imclone Systems (Nasdaq: IMCL)

Inverness Medical Innovations (Amex: IMA)

Invitrogen Corp. (Nasdaq: IVGN)

Medarex Inc. (Nasdaq: MEDX)

Medicis Pharmaceutical (NYSE: MRX)

Mentor Corp. (NYSE: MNT)

ONYX Pharmaceuticals Inc. (Nasdaq: ONXX)

PDL BioPharma, Inc. (Nasdaq: PDLI)

Pharmion Corp. (Nasdaq: PHRM)

Progenics Pharmaceuticals Inc. (Nasdaq: PGNX)

Regeneron Pharmaceuticals (Nasdaq: REGN)

Respironics Inc. (Nasdaq: RESP)

Sepracor Inc. (Nasdaq: SEPR)

Theravance Inc. (Nasdaq: THRX)

United Therapeutics Corp. (Nasdaq: UTHR)

Valeant Pharmaceuticals Int'l (NYSE: VRX)

Vertex Pharmaceuticals (Nasdaq: VRTX)


Adolor Corp. (Nasdaq: ADLR)


Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY)

Alpharma Inc. (NYSE: ALO)

Altus Pharmaceuticals Inc. (Nasdaq: ALTU)

AMAG Pharmaceuticals Inc. (Nasdaq: AMAG)


Ark Therapeutics (LSE: AKT.L)

Bavarian Nordic A/S (Copenhagen: BAVA.CO)

Caraco Pharmaceutical Laboratories Ltd. (Amex: CPD)

Cardiome Pharma Corp. (Nasdaq: CRME)

Coventry Health Care Inc. (NYSE: CVH)



Discovery Laboratories Inc. (Nasdaq: DSCO)

Eisai Co. Ltd. (TSE: 4523.T)

Encysive Pharmaceuticals Inc. (Nasdaq: ENCY)

Enzo Biochem Inc. (NYSE: ENZ)


Exelixis Inc. (Nasdaq: EXEL)

Flamel Technologies (Nasdaq: FLML)

Illumina Inc. (Nasdaq: ILMN)

Incyte Corporation (Nasdaq: INCY)

Integra LifeSciences Holdings (Nasdaq: IART)

Meda AB (Stockholm: MEDAA.ST)

Mitsubishi Tanabe Pharma (TSE: 4508.T)

Taisho Pharmaceutical Co., Ltd. (TSE: 4535.T)

Dermatology and Wound Index (HRW)


Shire PLC (ADR) (Nasdaq: SHPGY)

SkyePharma Plc (LSE: SKP.LN)


Standard Chemical & Pharm. Co., Ltd. (TSE: 1720)

Taisho Pharmaceutical Co., Ltd. (TSE: 4535)

Diagnostics Index (HHD)


CR Bard, Inc. (NYSE: BCR)

IDEXX Laboratories (Nasdaq: IDXX)


Bruker Corporation (Nasdaq: BRKR)

Halozyme Therapeutic (Nasdaq: HALO)

Emerging Cancer Index (HHJ)


Adventrx Pharmaceuticals, Inc. (Amex: ANX)

Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX)

SOURCE QED International Associates Inc.,
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Spectral announces new findings on the effectiveness of EAA(TM)/Toraymyxin(TM) at the 28th International Symposium on Intensive Care and Emergency Medicine
2. PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference
3. China Yingxia International Announces Q4 and FY 2007 Estimates
4. CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement
5. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
6. International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy
7. Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum
8. QED International Associates Announces Changes to the HealthShares(TM) Dermatology and Wound Care Index
9. IBF Conferences Inc., (International Business Forum) and BioEnterprise Present the 2nd Annual Global Healthcare Investing Conference
10. PAREXEL International Announces 2-For-1 Stock Split
11. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended September ... in Canadian dollars and presented under International Financial ... States ," said Andrew Rae , ... regarding iCo-008 are not only value enriching for ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... November 24, 2015 SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ... Officer, will participate in the Piper Jaffray 27 th Annual ... on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. ...
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Twist ... announced that Emily Leproust, Ph.D., Twist Bioscience chief ... Jaffray Healthcare Conference on December 1, 2015 at ... Hotel in New York City. --> ... . Twist Bioscience is on Twitter. ...
Breaking Biology Technology:
(Date:11/17/2015)... Paris from 17 th until 19 ... from 17 th until 19 th November 2015. ... invented the first combined scanner in the world which scans ... now two different scanners were required: one for passports and ... the same surface. This innovation is an ideal solution for ...
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
Breaking Biology News(10 mins):